{"id":"W4408207574","doi":"10.1093/braincomms/fcaf103","title":"<i>LRRK2</i> -associated parkinsonism with and without <i>in vivo</i> evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization","year":2025,"lang":"en","type":"article","venue":"Brain Communications","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"National Institute on Aging; Avid Radiopharmaceuticals; H. Lundbeck A/S; Servier; Voyager Therapeutics; Union Chimique Belge; Bristol-Myers Squibb; Aligning Science Across Parkinson’s; Neurocrine Biosciences; Cerevel Therapeutics; Jazz Pharmaceuticals; Takeda Pharmaceuticals U.S.A.; Denali Commission; AbbVie; Janssen Biotech; Teva Pharmaceutical Industries; Verily Life Sciences; Amathus Therapeutics; Biohaven Pharmaceuticals; Celgene; Pfizer; Biogen; Roche; Michael J. Fox Foundation for Parkinson's Research; Sanofi; Weston Family Foundation; Merck","keywords":"Parkinsonism; Biomarker; Alpha-synuclein; In vivo; LRRK2; Parkinson's disease; Neuroscience; Medicine; Chemistry; Psychology; Pathology; Biology; Disease; Biochemistry; Genetics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006113146,0.0001539274,0.0003822459,0.000147089,0.0001616922,0.00002865477,0.0001732244,0.00009773952,0.00001046643],"category_scores_gemma":[0.0004514498,0.0001315881,0.00004632416,0.000395539,0.0003976809,0.0001472541,0.0001854083,0.0001726828,0.000001235148],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003606199,"about_ca_system_score_gemma":0.0001495212,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000107001,"about_ca_topic_score_gemma":0.0002636877,"domain_scores_codex":[0.998669,0.000316911,0.0004171716,0.0002987711,0.0001373755,0.0001608249],"domain_scores_gemma":[0.9981792,0.0006006631,0.000201396,0.0007968578,0.0001145947,0.0001073109],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003575689,0.0007950078,0.9794565,0.00007880878,0.0002465658,0.000006761324,0.0001305816,1.347354e-7,0.006088759,0.0008101203,0.0001107791,0.01191846],"study_design_scores_gemma":[0.003200617,0.0002282635,0.98461,0.00201448,0.0002697791,0.00001324896,0.00005360675,0.001503014,0.0005195421,0.0002109904,0.007256783,0.0001196581],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.987118,0.003381846,0.0003568391,0.007891705,0.00002797008,0.0005754111,0.00004985322,0.00004119956,0.0005571422],"genre_scores_gemma":[0.9923545,0.004690341,0.001715496,0.0007861358,0.000004997167,0.0000761897,0.00005581218,0.00001499764,0.0003015294],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0117988,"threshold_uncertainty_score":0.5366007,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06547407372849434,"score_gpt":0.3627749359706621,"score_spread":0.2973008622421677,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}